Tamoxifen News and Research

RSS
Tamoxifen is a drug used to treat certain types of breast cancer in women and men. It is also used to prevent breast cancer in women who have had ductal carcinoma in situ (abnormal cells in the ducts of the breast) and in women who are at a high risk of developing breast cancer. Tamoxifen is also being studied in the treatment of other types of cancer. It blocks the effects of the hormone estrogen in the breast. Tamoxifen is a type of antiestrogen. Also called tamoxifen citrate.
Radiation therapy and tamoxifen helps prevent cancer returning

Radiation therapy and tamoxifen helps prevent cancer returning

Researchers show gossypol – a drug refined from cottonseed oil is a cancer treatment booster

Researchers show gossypol – a drug refined from cottonseed oil is a cancer treatment booster

Scientists embark on a five-year study of the effects of soy isoflavones found in dietary supplements on various body tissues

Scientists embark on a five-year study of the effects of soy isoflavones found in dietary supplements on various body tissues

Small proportion of women eligible for discussions about use of tamoxifen to prevent cancer

Small proportion of women eligible for discussions about use of tamoxifen to prevent cancer

New project to tailor health messages for African Americans based on their ethnic identity

New project to tailor health messages for African Americans based on their ethnic identity

Women over 70 are safe to not have radiation treatment after heaving a lumpectomy

Women over 70 are safe to not have radiation treatment after heaving a lumpectomy

Surgery plus radiation therapy an effective way to treat early breast cancer in women aged 70 and older

Surgery plus radiation therapy an effective way to treat early breast cancer in women aged 70 and older

Receptor for estrogen in ovarian cells has been shown to suppress tumor growth

Receptor for estrogen in ovarian cells has been shown to suppress tumor growth

The largest North American breast cancer prevention trial ever undertaken has reached its goal of enrolling 19,000 women

The largest North American breast cancer prevention trial ever undertaken has reached its goal of enrolling 19,000 women

Adhering to established guidelines improves survival and reduces the risk of breast cancer

Adhering to established guidelines improves survival and reduces the risk of breast cancer

New early breast cancer treatment significantly reduces the risk of cancer returning

New early breast cancer treatment significantly reduces the risk of cancer returning

Strategic analysis of the breast cancer therapeutics pipeline

Strategic analysis of the breast cancer therapeutics pipeline

Stress may increase risk for the most common type of uterine cancer

Stress may increase risk for the most common type of uterine cancer

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

Cognitive decline can occur before chemotherapy treatment

Cognitive decline can occur before chemotherapy treatment

Cancer drug gefitinib (Iressa) may be able to restore tamoxifen's anticancer activity

Cancer drug gefitinib (Iressa) may be able to restore tamoxifen's anticancer activity

Better understanding of Tamoxifen and how breast cancer patients develop resistance

Better understanding of Tamoxifen and how breast cancer patients develop resistance

New treatment significantly improves long-term outlook for breast cancer survivors

New treatment significantly improves long-term outlook for breast cancer survivors

Gene mutation found in some women may decrease effectiveness of tamoxifen breast cancer drug

Gene mutation found in some women may decrease effectiveness of tamoxifen breast cancer drug

Serum estrogen receptor modulator's (SERM's) may help reduce postmenopausal breast cancer risk

Serum estrogen receptor modulator's (SERM's) may help reduce postmenopausal breast cancer risk